NCT03939182: Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma |
|
|
| Active, not recruiting | 1 | 15 | US | Abexinostat, Ibrutinib | Memorial Sloan Kettering Cancer Center, Janssen Scientific Affairs, LLC, Xynomic Pharmaceuticals, Inc. | Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma | 05/25 | 05/25 | | |
